Terrence Duffy - CME Executive Chairman of the Board and Presidentident
| MX4A Stock | EUR 224.65 2.35 1.04% |
Chairman
Hon. Terrence A. Duffy was appointed as Executive Chairman of the Board, Chief Executive Officer of the Company. Mr. Duffy has served as our Chairman and Chief Executive Officer since November 2016. Previously, he served as our Executive Chairman President since 2012 and as our Executive Chairman since 2006, when he became an officer of the company. He served as Chairman of the board since 2002 and as our Vice Chairman from 1998 until 2002. Mr. Duffy was a member of our board since 1995. He was President of TDA Trading, Inc. from 1981 to 2002 and was a member of CME since 1981. Mr. Duffy was appointed by President Bush and confirmed by the U.S. Senate in 2003 as a member of the Federal Retirement Thrift Investment Board, a position he held until 2013. Mr. Duffy currently serves as CoChair of the Mayo Clinic Greater Chicago Leadership Council. He is a Vice Chairman of the CME Group Foundation, whose mission is to enhance economic opportunity, health and education, especially for disadvantaged youth. He is also a member of the Economic Club of Chicago, the Executives Club of Chicago and the Presidents Circle of the Chicago Council on Global Affairs. Since 2003, Mr. Duffy was recognized as one of the top 100 Irish Business Leaders by Irish America Magazine since 2016.
| Age | 65 |
| Tenure | 8 years |
| Professional Marks | Ph.D |
| Phone | 312 930 1000 |
| Web | https://www.cmegroup.com |
CME Management Efficiency
The company has return on total asset (ROA) of 0.0101 % which means that it generated a profit of $0.0101 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0992 %, meaning that it generated $0.0992 on every $100 dollars invested by stockholders. CME's management efficiency ratios could be used to measure how well CME manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 2 records | CHAIRMAN Age | ||
| Russell Tate | Collins Foods Limited | N/A | |
| Robert Kaye | Collins Foods Limited | N/A | |
Management Performance
| Return On Equity | 0.0992 | |||
| Return On Asset | 0.0101 |
CME Group Leadership Team
Elected by the shareholders, the CME's board of directors comprises two types of representatives: CME inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CME. The board's role is to monitor CME's management team and ensure that shareholders' interests are well served. CME's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CME's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Hilda Piell, Chief Human Resource Officer, Senior Managing Director | ||
| Terrence Duffy, Executive Chairman of the Board and Presidentident | ||
| Anita Liskey, Sr Communications | ||
| Jonathan Marcus, Sr Counsel | ||
| John Peschier, Managing Relations | ||
| Eileen Keeve, Managing Devel | ||
| Sunil Cutinho, President - CME Clearing | ||
| Jack Tobin, Chief Accounting Officer, Managing Director | ||
| Julie Holzrichter, Senior Managing Director - Global Operations |
CME Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CME a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0992 | |||
| Return On Asset | 0.0101 | |||
| Profit Margin | 0.54 % | |||
| Operating Margin | 0.60 % | |||
| Current Valuation | 60.85 B | |||
| Shares Outstanding | 359.72 M | |||
| Shares Owned By Insiders | 0.45 % | |||
| Shares Owned By Institutions | 88.31 % | |||
| Price To Earning | 35.53 X | |||
| Price To Book | 2.16 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in CME Stock
When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.